Title:
LIPOXIN A4 ANALOGS
Document Type and Number:
WIPO Patent Application WO2003040080
Kind Code:
A3
Abstract:
This invention is directed to lipoxin A4 analogs of the following formulas (I) and (II), wherein R<1>, R<2>, R<3>, R<4> and R<5> are described herein. These analogs are useful in treating inflammatory and autoimmune disorders in humans. These analogs are also useful in treating pulmonary or respiratory tract inflammation in humans.
More Like This:
| JP2004503523 | HIV integrase inhibitor |
| JPS59212488 | DIOXOLE DERIVATIVE |
| WO/2019/229384 | MONOETHYLENICALLY UNSATURATED MONOMERS AND USES THEREOF |
Inventors:
BAUMAN JOHN G (US)
GUILFORD WILLIAM J (US)
PARKINSON JOHN F (US)
SKUBALLA WERNER (DE)
SUBRAMANYAM BABU (US)
GUILFORD WILLIAM J (US)
PARKINSON JOHN F (US)
SKUBALLA WERNER (DE)
SUBRAMANYAM BABU (US)
Application Number:
PCT/US2002/035318
Publication Date:
January 29, 2004
Filing Date:
November 05, 2002
Export Citation:
Assignee:
SCHERING AG (DE)
BAUMAN JOHN G (US)
GUILFORD WILLIAM J (US)
PARKINSON JOHN F (US)
SKUBALLA WERNER (DE)
SUBRAMANYAM BABU (US)
BAUMAN JOHN G (US)
GUILFORD WILLIAM J (US)
PARKINSON JOHN F (US)
SKUBALLA WERNER (DE)
SUBRAMANYAM BABU (US)
International Classes:
C07D317/40; A61K31/16; A61K31/19; A61K31/202; A61K31/216; A61K31/357; A61K31/39; A61K31/42; A61P1/02; A61P3/10; A61P7/04; A61P9/10; A61P9/12; A61P11/00; A61P13/08; A61P13/12; A61P17/00; A61P17/06; A61P19/02; A61P25/00; A61P25/06; A61P25/16; A61P25/28; A61P27/02; A61P27/16; A61P29/00; A61P31/00; A61P31/18; A61P35/00; A61P35/02; A61P37/00; A61P37/02; A61P37/06; A61P37/08; C07C59/135; C07C59/68; C07C59/70; C07C69/708; C07C69/736; C07C209/68; C07C217/46; C07C229/12; C07C235/06; C07C323/52; C07D263/24; C07D317/22; C07D317/72; C07D327/04; (IPC1-7): C07C65/28; C07C65/40; C07C59/66; C07C59/64; C07C69/734; C07C69/738; C07C69/92; A61P37/00; A61P31/00; A61K31/202; A61K31/216
Domestic Patent References:
| WO1998011049A1 | 1998-03-19 | |||
| WO1994029262A1 | 1994-12-22 | |||
| WO1995001179A1 | 1995-01-12 | |||
| WO2000055109A1 | 2000-09-21 | |||
| WO2000054767A1 | 2000-09-21 | |||
| WO2000054761A2 | 2000-09-21 |
Foreign References:
| US6100296A | 2000-08-08 | |||
| US5441951A | 1995-08-15 |
Other References:
SERHAN C N ET AL: "ASPIRIN-TRIGGERED 15-EPI-LIPOXIN A4 AND NOVEL LIPOXIN B4 STABLE ANALOGS INHIBIT NEUTROPHIL-MEDIATED CHANGES IN VASCULAR PERMEABILITY", ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, SPRING ST., NY, US, vol. 469, 1999, pages 287 - 293, XP000925756, ISSN: 0065-2598
TAKANO T ET AL: "NEUTROPHIL-MEDIATED CHANGES IN VASCULAR PERMEABILITY ARE INHIBITED BY TOPICAL APPLICATION OF ASPIRIN-TRIGGERED 15-EPI-LIPOXIN A4 AND NOVEL LIPOXIN B4 STABLE ANALOGUES", JOURNAL OF CLINICAL INVESTIGATION, NEW YORK, NY, US, vol. 101, no. 4, February 1998 (1998-02-01), pages 819 - 826, XP000923075, ISSN: 0021-9738
MADDOX J F ET AL: "Lipoxin A4 Stable Analogs are potent Mimetics that stimulate human monocytes and THP-1 cells via a G-protein-coupled Lipoxin A4 Receptor", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 272, no. 11, 14 March 1997 (1997-03-14), pages 6972 - 6978, XP002183863, ISSN: 0021-9258
TAKANO T ET AL: "NEUTROPHIL-MEDIATED CHANGES IN VASCULAR PERMEABILITY ARE INHIBITED BY TOPICAL APPLICATION OF ASPIRIN-TRIGGERED 15-EPI-LIPOXIN A4 AND NOVEL LIPOXIN B4 STABLE ANALOGUES", JOURNAL OF CLINICAL INVESTIGATION, NEW YORK, NY, US, vol. 101, no. 4, February 1998 (1998-02-01), pages 819 - 826, XP000923075, ISSN: 0021-9738
MADDOX J F ET AL: "Lipoxin A4 Stable Analogs are potent Mimetics that stimulate human monocytes and THP-1 cells via a G-protein-coupled Lipoxin A4 Receptor", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 272, no. 11, 14 March 1997 (1997-03-14), pages 6972 - 6978, XP002183863, ISSN: 0021-9258
Download PDF:
Previous Patent: METHOD FOR PRODUCTION OF FORMIC ACID FORMATES
Next Patent: IMPROVEMENTS IN OR RELATING TO A METHOD FOR TRANSESTERIFYING VEGETABLE OILS
Next Patent: IMPROVEMENTS IN OR RELATING TO A METHOD FOR TRANSESTERIFYING VEGETABLE OILS